Furthermore, fusion of ZMYND8 has been identified in lymphoma and breast cancer; both of the ZMYND8 fusions reportedly remove the MYND domain but retain the N-terminal PBP cassette [64, 65]. Here, ZMYND8 is linked to lymphoma.